Literature DB >> 10839308

Mortality from cutaneous melanoma: evidence for contrasting trends between populations.

G Severi1, G G Giles, C Robertson, P Boyle, P Autier.   

Abstract

In recent years several reports have been published concerning trends in melanoma mortality in different countries, some of which have indicated that rates are beginning to fall. Many of these reports, however, have been based on small populations and have used different forms of statistical analysis. Our objective was to analyse systematically to what degree the epidemic of melanoma mortality had evolved similarly in different populations and whether there were any divergent trends that might increase our understanding. Instead of using all available data, we focused on countries with a minimum time series of 30 years and a minimum of 100 deaths annually in at least one sex from melanoma. We first inspected sex-specific age-standardized mortality rates and then performed age-period-cohort modelling. We found that the increase in mortality observed after 1950 was more pronounced in the age group 60-79. Statistical modelling showed a general increase in mortality rates in generations born after the turn of the century. Downturns in mortality, essentially in women and starting with generations born just before World War II, were found in Australia (where the earliest decreases were noted), the Nordic countries and the USA. Small decreases in rates in more recent generations were found in the UK and Canada. However, in France, Italy and Czechoslovakia, mortality rates were seen to be still increasing in recent cohorts. Our analysis suggests that populations are at different places on the melanoma mortality epidemic curve. The three trend patterns we observed are in agreement with time differences between populations with respect to the promotion of sun protection and the surveillance of pigmented skin lesions.

Entities:  

Mesh:

Year:  2000        PMID: 10839308      PMCID: PMC2363233          DOI: 10.1054/bjoc.1999.1243

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  International trends in cutaneous melanoma.

Authors:  A J Swerdlow
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

2.  Audit of public education campaign to encourage earlier detection of malignant melanoma.

Authors:  R M MacKie; D Hole
Journal:  BMJ       Date:  1992-04-18

3.  The estimation of age, period and cohort effects for vital rates.

Authors:  T R Holford
Journal:  Biometrics       Date:  1983-06       Impact factor: 2.571

4.  Cohort analysis of malignant melanoma in five countries.

Authors:  D J Venzon; S H Moolgavkar
Journal:  Am J Epidemiol       Date:  1984-01       Impact factor: 4.897

5.  A reversal in the long-term increase in deaths attributable to malignant melanoma.

Authors:  G C Roush; L McKay; T R Holford
Journal:  Cancer       Date:  1992-04-01       Impact factor: 6.860

6.  Trends in mortality from cutaneous malignant melanoma in Belgium.

Authors:  L Bleyen; D De Bacquer; K Myny; L Brochez; J M Naeyaert; G De Backer
Journal:  Int J Epidemiol       Date:  1999-02       Impact factor: 7.196

7.  Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age.

Authors:  C La Vecchia; F Lucchini; E Negri; F Levi
Journal:  Int J Cancer       Date:  1999-03-31       Impact factor: 7.396

8.  Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group.

Authors:  R MacKie; J A Hunter; T C Aitchison; D Hole; K Mclaren; R Rankin; K Blessing; A T Evans; A W Hutcheon; D H Jones
Journal:  Lancet       Date:  1992-04-18       Impact factor: 79.321

9.  Indications of future decreasing trends in skin-melanoma mortality among whites in the United States.

Authors:  J Scotto; H Pitcher; J A Lee
Journal:  Int J Cancer       Date:  1991-10-21       Impact factor: 7.396

10.  The influence of age, year of birth, and date on mortality from malignant melanoma in the populations of England and Wales, Canada, and the white population of the United States.

Authors:  J A Lee; G R Petersen; R G Stevens; K Vesanen
Journal:  Am J Epidemiol       Date:  1979-12       Impact factor: 4.897

View more
  7 in total

1.  Melanoma incidence increases in the elderly of Catalonia but not in the younger population: effect of prevention or consequence of immigration?

Authors:  Susana Puig; Joaquim Marcoval; Cristina Paradelo; Antoni Azon; Ramon Bartralot; Susana Bel; Xavier Bigata; Aram Boada; Antoni Campoy; Cristina Carrera; Neus Curco; Joan Dalmau; Carlos Ferrándiz; Josep R Ferreres; Manel Formigon; Fernando Gallardo; Alberto Gonzalez; Miquel Just; Enric Llistosella; Rosa M Marti; M Elena Nogues; Ramon Pedragosa; Josep A Pujol; Rodrigo Roldán-Marín; Mireia Sabat; Montserrat Salleras; Juan A Smandia; Pedro Zaballos; Estel Plana; Josep Malvehy
Journal:  Acta Derm Venereol       Date:  2015-04       Impact factor: 4.437

2.  Burden of illness for metastatic melanoma in Canada, 2011-2013.

Authors:  D S Ernst; T Petrella; A M Joshua; A Hamou; M Thabane; S Vantyghem; F Gwadry-Sridhar
Journal:  Curr Oncol       Date:  2016-12-21       Impact factor: 3.677

3.  The UK Government two-week rule and its impact on melanoma prognosis: an evidence-based study.

Authors:  M D Pacifico; R A Pearl; R Grover
Journal:  Ann R Coll Surg Engl       Date:  2007-09       Impact factor: 1.891

4.  Cancer mortality trends in the Umbria region of Italy 1978-2004: a joinpoint regression analysis.

Authors:  Fabrizio Stracci; Antonio Canosa; Liliana Minelli; Anna Maria Petrinelli; Tiziana Cassetti; Carlo Romagnoli; Francesco La Rosa
Journal:  BMC Cancer       Date:  2007-01-16       Impact factor: 4.430

5.  The relation between mortality from malignant melanoma and early detection in the Cancer Research Campaign Mole Watcher Study.

Authors:  J Melia; S Moss; D Coleman; T Frost; R Graham-Brown; J A Hunter; R A Marsden; A du Vivier; A P Warin; J White; S M Whitehead; M A Wroughton
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640

6.  A comparison of trends in melanoma mortality in New Zealand and Australia: the two countries with the highest melanoma incidence and mortality in the world.

Authors:  Mary Jane Sneyd; Brian Cox
Journal:  BMC Cancer       Date:  2013-08-06       Impact factor: 4.430

Review 7.  Melanoma Radiological Surveillance: A Review of Current Evidence and Clinical Challenges.

Authors:  Matthew David Howard
Journal:  Yale J Biol Med       Date:  2020-03-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.